SoftOx Solutions AS (OSL:SOFTX)
Norway · Delayed Price · Currency is NOK 0.1005
+0.0015 (1.52%)
At close: Aug 1, 2025
Heartland Financial USA Revenue
SoftOx Solutions AS had revenue of 3.22M NOK in the quarter ending March 31, 2025, with 77.19% growth. This brings the company's revenue in the last twelve months to 9.31M, down -1,160.92% year-over-year. In the year 2024, SoftOx Solutions AS had annual revenue of 7.91M with 13.38% growth.
Revenue (ttm)
9.31M
Revenue Growth
-1,160.92%
P/S Ratio
24.17
Revenue / Employee
4.66M
Employees
2
Market Cap
225.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.91M | 934.00K | 13.38% |
| Dec 31, 2023 | 6.98M | -133.61K | -1.88% |
| Dec 31, 2022 | 7.11M | -787.80K | -9.97% |
| Dec 31, 2021 | 7.90M | -1.94M | -19.69% |
| Dec 31, 2020 | 9.84M | 5.74M | 140.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 603.92M |
| Nordhealth AS | 545.88M |
| Photocure ASA | 532.69M |
| Vistin Pharma ASA | 440.66M |
| Omda AS | 442.14M |
| ArcticZymes Technologies ASA | 102.97M |
| Gentian Diagnostics ASA | 163.38M |
| Lytix Biopharma AS | 608.00K |